This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glaxosmithkline LLC. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Andrew Spaltenstein: Innovator in Pharmaceutical Compositions
Introduction
Andrew Spaltenstein is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at combating Human Immunodeficiency Virus (HIV) infections.
Latest Patents
Andrew holds a patent for pharmaceutical compositions that involve long-acting betulin derivatives or pharmaceutically acceptable salts. This invention is particularly useful in the treatment or prevention of HIV infections, showcasing his commitment to addressing critical health challenges.
Career Highlights
Andrew is currently associated with GlaxoSmithKline LLC, a leading global healthcare company. His work at GlaxoSmithKline has allowed him to focus on innovative solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Andrew has collaborated with talented individuals such as Shenshen Cai and Brian Alvin Johns. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Andrew Spaltenstein's work in pharmaceutical compositions highlights his dedication to innovation in healthcare. His contributions are vital in the ongoing fight against HIV, and his collaborations further enhance the impact of his inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile